ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Biocon Pharma UK Limited

Biocon Pharma UK Limited is an active company incorporated on 7 December 2018 with the registered office located in London, Greater London. Biocon Pharma UK Limited was registered 6 years ago.
Status
Active
Active since incorporation
Company No
11716196
Private limited company
Age
6 years
Incorporated 7 December 2018
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 6 December 2024 (11 months ago)
Next confirmation dated 6 December 2025
Due by 20 December 2025 (1 month remaining)
Last change occurred 1 year 10 months ago
Accounts
Submitted
For period 1 Apr31 Mar 2025 (12 months)
Accounts type is Small
Next accounts for period 31 March 2026
Due by 31 December 2026 (1 year 1 month remaining)
Address
16 Great Queen Street
Covent Garden
London
WC2B 5AH
United Kingdom
Same address since incorporation
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • Indian • Lives in India • Born in Mar 1953
Director • British • Lives in UK • Born in Jul 1957
Director • American • Lives in United States • Born in Dec 1975
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Mina Therapeutics Limited
Peter James Jonathan Bains is a mutual person.
Active
Apterna Limited
Peter James Jonathan Bains is a mutual person.
Active
Mina Alpha Limited
Peter James Jonathan Bains is a mutual person.
Active
Indivior Plc
Peter James Jonathan Bains is a mutual person.
Active
Mina (Holdings) Limited
Peter James Jonathan Bains is a mutual person.
Active
Mina Beta Limited
Peter James Jonathan Bains is a mutual person.
Active
ILC Therapeutics Ltd
Peter James Jonathan Bains is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2020–2025)
Period Ended
31 Mar 2025
For period 31 Mar31 Mar 2025
Traded for 12 months
Cash in Bank
£146.72K
Increased by £109.54K (+295%)
Turnover
Unreported
Same as previous period
Employees
4
Same as previous period
Total Assets
£3.34M
Increased by £1.94M (+138%)
Total Liabilities
-£3.97M
Increased by £1.85M (+87%)
Net Assets
-£630.09K
Increased by £86.58K (-12%)
Debt Ratio (%)
119%
Decreased by 32.23% (-21%)
Latest Activity
Small Accounts Submitted
4 Months Ago on 30 Jun 2025
Confirmation Submitted
11 Months Ago on 11 Dec 2024
Small Accounts Submitted
1 Year 3 Months Ago on 25 Jul 2024
Confirmation Submitted
1 Year 10 Months Ago on 10 Jan 2024
Mr Peter James Jonathan Bains Details Changed
1 Year 10 Months Ago on 9 Jan 2024
Small Accounts Submitted
2 Years 2 Months Ago on 16 Aug 2023
Mr Peter James Jonathan Bains Appointed
2 Years 6 Months Ago on 17 Apr 2023
Small Accounts Submitted
2 Years 9 Months Ago on 31 Jan 2023
Confirmation Submitted
2 Years 11 Months Ago on 14 Dec 2022
John Mccallum Marshall Shaw Resigned
3 Years Ago on 24 Oct 2022
Get Credit Report
Discover Biocon Pharma UK Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Accounts for a small company made up to 31 March 2025
Submitted on 30 Jun 2025
Confirmation statement made on 6 December 2024 with no updates
Submitted on 11 Dec 2024
Accounts for a small company made up to 31 March 2024
Submitted on 25 Jul 2024
Confirmation statement made on 6 December 2023 with updates
Submitted on 10 Jan 2024
Director's details changed for Mr Peter James Jonathan Bains on 9 January 2024
Submitted on 9 Jan 2024
Accounts for a small company made up to 31 March 2023
Submitted on 16 Aug 2023
Appointment of Mr Peter James Jonathan Bains as a director on 17 April 2023
Submitted on 26 Apr 2023
Accounts for a small company made up to 31 March 2022
Submitted on 31 Jan 2023
Particulars of variation of rights attached to shares
Submitted on 22 Dec 2022
Memorandum and Articles of Association
Submitted on 22 Dec 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year